Sign in
ORAL ABSTRACT: ABCL-777 Initial Results From LOTIS-7: A Phase 1b Study of Loncastuximab Tesirine Plus Glofitamab in Patients With Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
Journal article   Peer reviewed

ORAL ABSTRACT: ABCL-777 Initial Results From LOTIS-7: A Phase 1b Study of Loncastuximab Tesirine Plus Glofitamab in Patients With Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)

Juan Pablo Alderuccio, Craig Okada, Gilles Crochet, Emily C. Ayers, Marie Hu, Silvia Ferrari, Paolo F. Caimi, Mehdi Hamadani, Julien Depaus, Enrico Derenzini, …
Clinical lymphoma, myeloma and leukemia, Vol.25, pp.S164-S164
2025-09

Metrics

1 Record Views

Details

Logo image